Skip to main content
TipRanks
Go Ultimate75% OFF

Evgen Pharma (TCF) Ratios

4 Followers

Evgen Pharma Ratios

GB:TCF's free cash flow for Q4 2025 was £-1.86M. For the 2025 fiscal year, GB:TCF's free cash flow was decreased by £-17.00K and operating cash flow was £-1.85M. See a summary of the company’s cash flow.

Financial ratios
RatiosMar 25Mar 24Mar 23Mar 22Mar 21
Liquidity Ratios
Current Ratio1.363.114.207.3623.31
Quick Ratio1.363.114.207.3623.31
Cash Ratio0.281.272.786.0010.97
Solvency Ratio-1.68-1.13-4.34-4.84-6.60
Operating Cash Flow Ratio-1.51-1.42-4.16-4.84-6.23
Short-Term Operating Cash Flow Coverage-231.550.000.000.000.00
Net Current Asset Value£ 193.00K£ 3.51M£ 2.31M£ 5.29M£ 9.17M
Leverage Ratios
Debt-to-Assets Ratio0.000.000.000.000.00
Debt-to-Equity Ratio0.000.000.000.000.00
Debt-to-Capital Ratio0.000.000.000.000.00
Long-Term Debt-to-Capital Ratio0.000.000.000.000.00
Financial Leverage Ratio1.771.281.311.161.04
Debt Service Coverage Ratio-330.180.000.000.000.00
Interest Coverage Ratio0.000.000.000.000.00
Debt to Market Cap0.000.000.000.000.00
Interest Debt Per Share0.000.000.000.000.00
Net Debt to EBITDA0.131.030.561.001.43
Profitability Margins
Gross Profit Margin0.00%0.00%97.22%97.06%0.00%
EBIT Margin0.00%0.00%-898.99%-1132.58%0.00%
EBITDA Margin0.00%0.00%-896.21%-1129.64%0.00%
Operating Profit Margin0.00%0.00%-898.99%-1147.06%0.00%
Pretax Profit Margin0.00%0.00%-900.51%-1132.58%0.00%
Net Profit Margin0.00%0.00%-792.17%-914.71%0.00%
Continuous Operations Profit Margin0.00%0.00%-792.17%-914.71%0.00%
Net Income Per EBT98.96%93.09%87.97%80.76%86.15%
EBT Per EBIT96.82%98.16%100.17%98.74%99.31%
Return on Assets (ROA)-73.35%-25.44%-102.45%-65.48%-28.33%
Return on Equity (ROE)-129.96%-32.52%-134.00%-75.70%-29.59%
Return on Capital Employed (ROCE)-117.81%-35.59%-152.07%-94.93%-34.58%
Return on Invested Capital (ROIC)-116.18%-35.59%-133.78%-76.67%-29.79%
Return on Tangible Assets-153.52%-37.54%-103.60%-65.94%-28.48%
Earnings Yield-84.33%-160.25%-134.26%-39.75%-28.38%
Efficiency Ratios
Receivables Turnover0.000.000.800.440.00
Payables Turnover0.0119.920.030.030.24
Inventory Turnover0.000.00-11.000.000.00
Fixed Asset Turnover0.000.00396.00147.330.00
Asset Turnover0.000.000.130.070.00
Working Capital Turnover Ratio0.000.000.100.060.00
Cash Conversion Cycle-38210.94-18.32-10525.09-10447.92-1505.63
Days of Sales Outstanding0.000.00458.09839.000.00
Days of Inventory Outstanding0.000.00-33.180.000.00
Days of Payables Outstanding38210.9418.3210950.0011286.921505.63
Operating Cycle0.000.00424.91839.000.00
Cash Flow Ratios
Operating Cash Flow Per Share-0.00-0.00-0.01-0.01-0.01
Free Cash Flow Per Share-0.00-0.00-0.01-0.01-0.01
Dividend Paid and CapEx Coverage Ratio-149.820.000.00-4029.00-853.33
Capital Expenditure Coverage Ratio-149.820.000.00-4029.00-853.33
Operating Cash Flow Coverage Ratio-231.550.000.000.000.00
Operating Cash Flow to Sales Ratio0.000.00-7.57-9.120.00
Free Cash Flow Yield-61.23%-195.43%-128.22%-39.62%-26.64%
Valuation Ratios
Price-to-Earnings (P/E) Ratio-1.22-0.63-0.74-2.52-3.52
Price-to-Sales (P/S) Ratio0.000.005.9023.010.00
Price-to-Book (P/B) Ratio1.540.201.001.901.04
Price-to-Free Cash Flow (P/FCF) Ratio-1.63-0.51-0.78-2.52-3.75
Price-to-Operating Cash Flow Ratio-1.64-0.51-0.78-2.52-3.76
Price-to-Earnings Growth (PEG) Ratio0.020.010.03-0.050.08
Enterprise Value Multiple-1.020.44-0.09-1.04-1.62
Enterprise Value3.73M-897.80K332.55K5.17M5.11M
EV to EBITDA-1.020.44-0.09-1.04-1.62
EV to Sales0.000.000.8411.700.00
EV to Free Cash Flow-1.450.38-0.11-1.28-1.99
EV to Operating Cash Flow-1.460.38-0.11-1.28-2.00
Tangible Book Value Per Share0.000.010.010.020.03
Shareholders’ Equity Per Share0.000.010.010.020.03
Tax and Other Ratios
Effective Tax Rate0.01-0.070.120.190.14
Revenue Per Share0.000.000.000.000.00
Net Income Per Share-0.00-0.00-0.01-0.01-0.01
Tax Burden0.990.930.880.810.86
Interest Burden0.970.981.001.001.00
Research & Development to Revenue0.000.006.9910.680.00
SG&A to Revenue0.000.002.931.730.00
Stock-Based Compensation to Revenue0.000.000.350.360.00
Income Quality0.721.140.841.000.94

Currency in GBP